CLS001

DRUG2 trials

Sponsors

Maruho Co., Ltd.

Conditions

Atopic DermatitisPapulopustular Rosacea

Phase 1

A 21 Day Pharmacokinetics Study in Papulopustular Rosacea

CompletedNCT02028286

Maruho Co., Ltd.Papulopustular Rosacea

Start: 2014-01-31Updated: 2014-04-14

Phase 2

Pharmacodynamics of Omiganan (CLS001) in Patients With Atopic Dermatitis

CompletedNCT02456480

Maruho Co., Ltd.Atopic Dermatitis

Start: 2015-05-31End: 2015-11-30Updated: 2016-07-28